The Latest Breaking News from FDA

SACRAMENTO, Calif. — The wife of a Northern California congressman died late last year after ingesting a plant that is generally considered safe and is used as an herbal remedy for a variety of ailments, including diabetes, obesity and high cholesterol, KHN has learned.

The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A (congenital Factor VIII deficiency) in adult patients. BioMarin shares traded as high as 2.28 percent, in a range of $91.39 to $93.68…

Mehmet Oz’s advocacy for the drug hydroxychloroquine in the early days of the COVID-19 pandemic is cited in a new congressional report that accuses former President Donald Trump’s administration of pressuring the Food and Drug Administration to endorse unproven treatments and vaccines.

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults

The likelihood that the Supreme Court considers the FDA's treatment of vaping products is increasing.

Congressional investigation finds new evidence of efforts to override health decisions early in pandemic

Recently, the Federal Trade Commission (FTC) announced that it will send payments to 576 consumers across the country who purchased 'deceptively marketed' cannabidiol (CBD) products from Arizona-based Kushly Industries LLC.

The former TV doctor, who two years ago said "we ought to completely change our policy on marijuana," mocks his opponent for agreeing.

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

A special House panel looking into the government's coronavirus response says the Trump White House tried to pressure U.S. health experts into reauthorizing the anti-malaria drug hydroxychloroquine that had been discredited as a COVID-19 treatment

Plus: Twitter whistleblower reports, court says FDA must reconsider vaping products, and more...